Cargando…
Author Correction: LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells
Autores principales: | Lim, So-Young, Macheleidt, Iris, Dalvi, Priya, Schäfer, Stephan C., Kerick, Martin, Ozretić, Luka, Ortiz-Cuaran, Sandra, George, Julie, Merkelbach-Bruse, Sabine, Wolf, Jürgen, Timmermann, Bernd, Thomas, Roman K., Schweiger, Michal R., Buettner, Reinhard, Odenthal, Margarete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210192/ https://www.ncbi.nlm.nih.gov/pubmed/30382114 http://dx.doi.org/10.1038/s41598-018-31451-0 |
Ejemplares similares
-
LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells
por: Lim, So-Young, et al.
Publicado: (2017) -
Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations
por: Macheleidt, Iris F., et al.
Publicado: (2018) -
Vesicular Release and Uptake of Circular LSD1-RNAs from Non-Cancer and Cancer Lung Cells
por: Galang, Joelle Noriko, et al.
Publicado: (2023) -
Use of the GeneReader NGS System in a clinical pathology laboratory: a comparative study
por: Koitzsch, Ulrike, et al.
Publicado: (2017) -
Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics
por: Heydt, Carina, et al.
Publicado: (2014)